Welcome to Prospect! We use the same data as VCs to help you find the best startups and understand what your equity is likely to be worth.
View more companies

Dexory

Dexory develops robotics and AI for warehouses, using its DexoryView platform to create real-time digital twins for operational insights.

Secondary Market Price

Updated: 
Jan 2026
Current Preferred Price
Date:
Sign in to view
Prospect Projected Preferred
Current FMV
Date:
Sign in to view
Prospect Projected FMV
$500M
Company Valuation
Updated: 
Jan 2026
Robotics
Industry
Wallingford, Oxfordshire
Headquarters
2015
Year Founded
170+
Employee Count

How Dexory Measures Up

To help you manage your Dexory equity, Prospect has run the company through our machine learning model.

Prospect Rating

--

This rating reflects our belief in this company's potential to grow to that many times its current value in 4 years. For an employee with stock, this rating suggests a potential return on equity, but it also comes with some risk.

Exit Risk

--

Our rating is a reflection of the likelihood of this company achieving a liquidity event for its employees based on the quality of investors, funding stage, founders, and more.

Funding Stage

Series C

A company’s funding stage reflects how established it is, how quickly it is scaling, and the average impact an employee may have when joining.

Est val $500M
--
Jan 28, 2026

Create a free account to unlock real-time secondary market prices and future projections of Dexory's value.

Sign up to Unlock the Latest Data
Failed to load data. Using sample data.
Loading chart…

Data will be available soon.
Sign up to receive notifications when it is available.

Sign up to get notified
Sign up to Unlock the Latest Data

Prospect Projected Future Dexory Prices

Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for Dexory's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.

Powerful tools to earn more from your equity

Company Description

Dexory, founded in 2015 as BotsAndUs, develops robotics and artificial intelligence solutions for the logistics industry. The company’s primary offering is DexoryView, a platform that uses autonomous robots to automate data collection within warehouses, creating real-time digital models that provide insights into operations and inventory. Co-founded by Adrian Negoita and Oana Jinga, the UK-based company has expanded globally with operations in Europe, North America, and the Asia-Pacific region. Dexory has deployed its technology in live production environments for clients including Stellantis, Samsung SDS, and Iron Mountain.

The company is currently focused on scaling its engineering and operations teams to support its global expansion, aided by a partnership with the firm NEUTRA. In November 2025, Dexory raised $100 million in a Series C funding round. The company has been recognized on The Sunday Times' AI Ones to Watch list and has received media coverage for its work, such as a CBS News Detroit feature on its robot deployment at a Stellantis assembly plant. Dexory is also preparing for a major announcement at the Manifest 2026 conference in Las Vegas.

Dexory Notable Investors

  • Eurazeo
  • LTS Growth
  • Endeavor Catalyst
  • DTCP
  • Atomico
  • Lakestar
  • Elaia
  • Latitude Ventures
  • Wave-X
  • Bootstrap Europe
  • Capnamic
  • Kindred
  • Maersk Growth
  • Schenker Ventures

Dexory Founders

  • Co-Founder, Andrei Danescu
  • Co-Founder, Adrian Negoita
  • Co-Founder, Oana Jinga

Peer Group Comparison

Vs Peer Group of >$4B Startups

Frequently Asked Questions

Is Anduril worth joining?

Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.

Is Dexory worth joining?

Evaluating an offer from a startup like Dexory requires looking at your role, the company's trajectory, and the total compensation package. Platforms like Prospect can help you analyze the potential value of your equity compensation to make a more informed career decision.

What should I do with my Dexory stock?

Managing private company stock involves complex decisions around exercising options, tax planning, and aligning with your personal financial goals. Using a service like Prospect can provide you with customized, multi-year strategies to help maximize the after-tax value of your equity.

Can you sell Dexory stock?

As a private company, Dexory stock can typically only be sold during specific liquidity events, such as a tender offer or on a secondary market. Prospect provides tender offer tools to help you decide how much to sell and which shares are most tax-optimal during these opportunities.

How can I find the value of my Dexory stock?

The value of private stock is typically based on the company's most recent 409A valuation and any available secondary market data. To help you look forward, Prospect offers proprietary models that forecast the future value of your shares using data relied on by top VCs.

What is Dexory's equity worth?

The precise worth of private equity fluctuates, but it can be estimated using the company's latest valuation and market data. Tools like Prospect can help you project a range of potential outcomes for your equity by analyzing various data points, similar to how VCs operate.

What is Dexory's stock ticker symbol?

As a private company, Dexory is not traded on a public stock exchange and therefore does not have a stock ticker symbol. Ticker symbols are assigned only when a company goes public through an Initial Public Offering (IPO).

Can I buy or sell Dexory stock?

Selling private stock is typically restricted to company-approved liquidity events, while buying is usually limited to employees exercising options or accredited investors on secondary markets. Prospect provides personalized option exercise strategies to help you navigate the complexities of acquiring and selling your shares tax-efficiently.

What is the criteria to buy or invest in Dexory stock?

Investing in a private company like Dexory is generally restricted to employees receiving equity compensation or accredited investors participating in funding rounds or secondary markets. The general public cannot typically buy shares until the company undergoes an IPO.

Ready to unlock insights on top performing startups?
Ready to unlock insights on top performing startups?